David Mulham Mulham - 08 Feb 2024 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
CHIEF SALES OFFICER
Signature
/s/ Joshua Foukas, Attorney-in-Fact
Issuer symbol
USNA
Transactions as of
08 Feb 2024
Net transactions value
$0
Form type
4
Filing time
12 Feb 2024, 17:13:28 UTC
Previous filing
08 Feb 2024
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USNA Common Stock Options Exercise +1,676 +16% 12,136 08 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Restricted Stock Units Options Exercise $0 -1,676 -12% $0.000000 11,921 08 Feb 2024 Common Stock 1,676 Direct F1, F2
transaction USNA Restricted Stock Units Award $0 +10,293 +86% $0.000000 22,214 08 Feb 2024 Common Stock 10,293 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2 Restricted Stock Units vest 25% on the anniversary of February 8th, 2021.
F3 On February 8th, 2024, the reporting person was granted restricted stock units, vesting at 25% on each 8th of February thereafter.